Zoladex questions answered by a medical oncologist

In this video, Vicki Durston, Executive Director of Policy Advocacy and Support Services at Breast Cancer Network Australia (BCNA), speaks with medical oncologist Dr Belinda Kiely to answer your questions about access to AstraZeneca's Zoladex (goserelin) 3.6mg implant.

You can also read more about Zoladex access and the work we are continuing to do with clinicians, consumers and key stakeholders to achieve a longer-term solution.

If you need support or would like to learn more about our advocacy on this issue, contact our Helpline.